Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kaiser

Showing results (471-480 of 554) with videos related to

Pageof 56
Sort By:
Microorganisms|December 24, 2021
Detection of Systemic Canine Kobuvirus Infection in Peripheral Tissues and the Central Nervous System of a Fox Infected with Canine Distemper VirusFranziska K Kaiser, Lydia van Dyck, Wendy K Jo, et al.
Ophthalmology|February 8, 2025
Determinants of Four-Year Visual Acuity Loss in Geographic Atrophy: An Analysis of Age-Related Eye Disease Study and Age-Related Eye Disease Study 2Liangbo Linus Shen, Peter K Kaiser, Jeremy Liu, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|January 19, 2012
24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Retina (Philadelphia, Pa.)|December 3, 2009
Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injectionsClement K Chan, Prema Abraham, Carsten H Meyer, et al.
The British Journal of Ophthalmology|August 10, 2016
Impact of initial visual acuity on anti-VEGF treatment outcomes in patients with macular oedema secondary to retinal vein occlusions in routine clinical practiceKaren M Wai, Mehnaz Khan, Sunil Srivastava, et al.
Survey of Ophthalmology|March 23, 2024
Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A reviewNeil M Bressler, Peter K Kaiser, Diana V Do, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|August 12, 2011
16-Gy low-voltage x-ray irradiation followed by as-needed ranibizumab therapy for AMD: 6-month outcomes of a "radiation-first" strategyAndrew A Moshfeghi, Virgilio Morales Canton, Hugo Quiroz-Mercado, et al.
American Journal of Ophthalmology|July 9, 2010
RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027Peter K Kaiser, R C Andrew Symons, Syed Mahmood Shah, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 15, 2017
Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical PracticeMehnaz Khan, Karen M Wai, Fabiana Q Silva, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|August 12, 2011
16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Pageof 56

Showing results (471-480 of 554) with videos related to

Sort By:
Pageof 56
Microorganisms|December 24, 2021
Detection of Systemic Canine Kobuvirus Infection in Peripheral Tissues and the Central Nervous System of a Fox Infected with Canine Distemper VirusFranziska K Kaiser, Lydia van Dyck, Wendy K Jo, et al.
Ophthalmology|February 8, 2025
Determinants of Four-Year Visual Acuity Loss in Geographic Atrophy: An Analysis of Age-Related Eye Disease Study and Age-Related Eye Disease Study 2Liangbo Linus Shen, Peter K Kaiser, Jeremy Liu, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|January 19, 2012
24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Retina (Philadelphia, Pa.)|December 3, 2009
Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injectionsClement K Chan, Prema Abraham, Carsten H Meyer, et al.
The British Journal of Ophthalmology|August 10, 2016
Impact of initial visual acuity on anti-VEGF treatment outcomes in patients with macular oedema secondary to retinal vein occlusions in routine clinical practiceKaren M Wai, Mehnaz Khan, Sunil Srivastava, et al.
Survey of Ophthalmology|March 23, 2024
Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A reviewNeil M Bressler, Peter K Kaiser, Diana V Do, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|August 12, 2011
16-Gy low-voltage x-ray irradiation followed by as-needed ranibizumab therapy for AMD: 6-month outcomes of a "radiation-first" strategyAndrew A Moshfeghi, Virgilio Morales Canton, Hugo Quiroz-Mercado, et al.
American Journal of Ophthalmology|July 9, 2010
RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027Peter K Kaiser, R C Andrew Symons, Syed Mahmood Shah, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 15, 2017
Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical PracticeMehnaz Khan, Karen M Wai, Fabiana Q Silva, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|August 12, 2011
16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Pageof 56